Bioinformatics analysis of SARS-Cov M protein provides information for vaccine development

被引:0
|
作者
LIU Wanli
Protein Science Laboratory of MOE
机构
关键词
SARS-Cov; M protein; anti-SARS vaccine strategy;
D O I
暂无
中图分类号
R373 [人体病毒学(致病病毒)];
学科分类号
100103 ; 100705 ;
摘要
The pathogen causing severe acute respiratory syndrome (SARS) is identified to be SARS-Cov. It is urgent to know more about SARS-Cov for developing an efficient SARS vaccine to prevent this epidemic disease. In this report, the homology of SARS-Cov M protein to other members of coronavirus is illustrated, and all amino acid changes in both S and M proteins among all available SARS-Cov isolates in GenBank are described. Furthermore, one topological trans-membrane secondary structure model of M protein is proposed, which is corresponded well with the accepted topology model of M proteins of other members of coronavirus. Hydrophilic profile analysis indicated that one region (aa150~210) on the cytoplasmic domain is fairly hydrophilic, suggesting its property of antigenicity. Based on the fact that cytoplasmic domain of the M protein of some other coronavirus could induce protective activities against virus infection, this region might be one potential target for SARS vaccine development.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 50 条
  • [21] Spike protein of SARS coronavirus (SARS-CoV) induces protective immunity against subsequent SARS-CoV challenge in mice
    Bisht, H
    Roberts, A
    Vogel, L
    Bukreyev, A
    Lamirande, E
    Collins, P
    Murphy, B
    Subbarao, K
    Moss, B
    FASEB JOURNAL, 2005, 19 (04): : A894 - A894
  • [22] Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
    Fan Luo
    Fan-Lu Liao
    Hui Wang
    Hong-Bin Tang
    Zhan-Qiu Yang
    Wei Hou
    Virologica Sinica, 2018, 33 (02) : 201 - 204
  • [23] T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
    Liu, William J.
    Zhao, Min
    Liu, Kefang
    Xu, Kun
    Wong, Gary
    Tan, Wenjie
    Gao, George F.
    ANTIVIRAL RESEARCH, 2017, 137 : 82 - 92
  • [24] Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
    Luo, Fan
    Liao, Fan-Lu
    Wang, Hui
    Tang, Hong-Bin
    Yang, Zhan-Qiu
    Hou, Wei
    VIROLOGICA SINICA, 2018, 33 (02) : 201 - 204
  • [25] Viroporin activity of SARS-CoV E protein
    Liao, Ying
    Tam, James P.
    Liu, Ding X.
    NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 199 - 202
  • [26] Expression and identification of SARS-CoV nucleocapsid protein
    Zhao, B
    Jin, NY
    Wang, RL
    Zheng, M
    Zhang, YJ
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2005, 26 (11): : 2061 - 2065
  • [27] The Epitope Study on the SARS-CoV Nucleocapsid Protein
    Shuting Li
    Genomics Proteomics & Bioinformatics, 2003, (03) : 198 - 206
  • [28] Thermal aggregation of SARS-CoV membrane protein
    Lee, YN
    Chen, LK
    Ma, HC
    Yang, HH
    Li, HP
    Lo, SY
    JOURNAL OF VIROLOGICAL METHODS, 2005, 129 (02) : 152 - 161
  • [29] Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis
    Qin, L
    Xiong, B
    Luo, C
    Guo, ZM
    Hao, P
    Su, J
    Nan, P
    Feng, Y
    Shi, YX
    Yu, XJ
    Luo, XM
    Chen, KX
    Shen, X
    Shen, JH
    Zou, JP
    Zhao, GP
    Shi, TL
    He, WZ
    Zhong, Y
    Jiagn, HL
    Li, YX
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (06) : 489 - 496
  • [30] Generating Stable Chinese Hamster Ovary Cell Clones to Produce a Truncated SARS-CoV Spike Protein for Vaccine Development
    Lin, Shih-Chang
    Leng, Chih-Hsiang
    Wu, Suh-Chin
    BIOTECHNOLOGY PROGRESS, 2010, 26 (06) : 1733 - 1740